Literature DB >> 9626398

Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats.

T Onishi1, Y Ishidou, T Nagamine, K Yone, T Imamura, M Kato, T K Sampath, P ten Dijke, T Sakou.   

Abstract

Bone morphogenetic proteins (BMPs) and their receptors (BMPRs) are thought to play an important role in bone morphogenesis. The purpose of this study was to determine the locations of BMP-2/-4, osteogenic protein-1 (OP-1, also termed BMP-7), and BMP type II receptor (BMPR-II) during rat fracture healing by immunostaining, and thereby elucidate the possible roles of the BMPs and BMPR-II in intramembranous ossification and endochondral ossification. In the early stage of fracture repair, the expression of BMP-2/-4 and OP-1 was strongly induced in the thickened periosteum near the fracture ends, and coincided with an enhanced expression of BMPR-II. On day 7 after fracture, staining for BMP-2/-4 and OP-1 immunostaining was increased in various types of chondrocytes, and was strong in fibroblast-like spindle cells and proliferating chondrocytes in endochondral bone. On day 14 after fracture, staining with OP-1 antibody disappeared in proliferating and mature chondrocytes, while BMP-2/-4 staining continued in various types of chondrocytes until the late stage. In the newly formed trabecular bone, BMP-2/-4 and OP-1 were present at various levels. BMPR-II was actively expressed in both intramembranous ossification and endochondral ossification. Additionally, immunostaining for BMP-2/-4 and OP-1 was observed in multinucleated osteoclast-like cells on the newly formed trabecular bone, along with BMPR-II. In reference to our previous study of BMP type I receptors (BMPR-IA and BMPR-IB), BMPR-II was found to be co-localized with BMPR-IA and BMPR-IB. BMP-2/-4 and OP-1 antibodies exhibited distinct and overlapping immunostaining patterns during fracture repair. OP-1 may act predominantly in the initial phase of endochondral ossification, while BMP-2/-4 acts throughout this process. Thus, these findings suggested that BMPs acting through their BMP receptors may play major roles in modulating the sequential events leading to bone formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626398     DOI: 10.1016/s8756-3282(98)00056-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  48 in total

1.  [Injectable carrier system for growth factor application in minimally invasive stimulation of bone healing].

Authors:  H Windhagen; F Witte; F Thorey; C Hurschler; C J Wirth
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

Review 2.  Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration.

Authors:  Takanobu Nakase; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 3.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

Review 4.  Bone morphogenetic proteins in fracture repair.

Authors:  Ivo Dumic-Cule; Mihaela Peric; Lucija Kucko; Lovorka Grgurevic; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2018-09-15       Impact factor: 3.075

5.  [Bone tissue engineering. Reconstruction of critical sized segmental bone defects in the ovine tibia].

Authors:  J C Reichert; D R Epari; M E Wullschleger; A Berner; S Saifzadeh; U Nöth; I C Dickinson; M A Schuetz; D W Hutmacher
Journal:  Orthopade       Date:  2012-04       Impact factor: 1.087

6.  WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.

Authors:  Cheng Chen; Yi Qin; Jian-ping Fang; Xin-yan Ni; Jian Yao; Hai-ying Wang; Kan Ding
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

Review 7.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

8.  Immunohistochemical localization of the bone morphogenetic protein receptors in the porcine ovary.

Authors:  Ruth L Quinn; Gail Shuttleworth; Morag G Hunter
Journal:  J Anat       Date:  2004-07       Impact factor: 2.610

9.  Gene therapy to improve osteogenesis in bone lesions with severe soft tissue damage.

Authors:  Tim Rose; Hairong Peng; Arvydas Usas; Ryosuke Kuroda; Helmut Lill; Freddie H Fu; Johnny Huard
Journal:  Langenbecks Arch Surg       Date:  2003-09-20       Impact factor: 3.445

10.  Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures.

Authors:  Neil Ghodadra; Kern Singh
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.